ArticleMolecular cancer therapeutics2008

Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma.

François Lamoureux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.